These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3010697)

  • 1. Phase II study of vincristine infusion in refractory small cell carcinoma of the lung.
    Jackson DV; Pope EK; Hire EA; Spurr CL; Rardin DA; McCulloch J
    Am J Clin Oncol; 1985 Apr; 8(2):154-6. PubMed ID: 3010697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of vincristine infusion in acute leukemia.
    Jackson DV; Chauvenet AR; Callahan RD; Atkins JN; Trahey TF; Spurr CL
    Cancer Chemother Pharmacol; 1985; 14(1):26-9. PubMed ID: 3965157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous vincristine infusion: phase I trial.
    Jackson DV; Sethi VS; Spurr CL; Willard V; White DR; Richards F; Stuart JJ; Muss HB; Cooper MR; Homesley HD; Jobson VW; Castle MC
    Cancer; 1981 Dec; 48(12):2559-64. PubMed ID: 7306914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vincristine (NSC-67574) in the treatment of small-cell anaplastic carcinoma of the lung.
    Dombernowsky P; Hansen HH; Sorensen PG; Hainau B
    Cancer Treat Rep; 1976 Mar; 60(3):239-42. PubMed ID: 177209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced non-Hodgkin's lymphoma with vincristine infusion.
    Jackson DV; Paschold EH; Spurr CL; Muss HB; Richards F; Cooper MR; White DR; Stuart JJ; Hopkins JO; Rich R
    Cancer; 1984 Jun; 53(12):2601-6. PubMed ID: 6722721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vincristine by continuous infusion in refractory breast cancer: a phase II study.
    Hopkins JO; Jackson DV; White DR; Muss HB; Richards F; Cooper MR; Stuart JJ; Sparr CL; Wells HB
    Am J Clin Oncol; 1983 Oct; 6(5):529-32. PubMed ID: 6613919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vincristine infusion in refractory gynecologic malignancies.
    Jackson DV; Jobson VW; Homesley HD; Welander C; Hire EA; Pavy MD; Votaw ML; Richards F; Muss HB
    Gynecol Oncol; 1986 Oct; 25(2):212-6. PubMed ID: 3758831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I study of pegylated liposomal doxorubicin hydrochloride (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small-cell lung cancer.
    Leighl NB; Burkes RL; Dancey JE; Lopez PG; Higgins BP; David Walde PL; Rudinskas LC; Rahim YH; Rodgers A; Pond GR; Shepherd FA
    Clin Lung Cancer; 2003 Sep; 5(2):107-12. PubMed ID: 14596693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single agent vincristine by infusion in refractory multiple myeloma.
    Jackson DV; Case LD; Pope EK; White DR; Spurr CL; Richards F; Stuart JJ; Muss HB; Cooper MR; Black WR
    J Clin Oncol; 1985 Nov; 3(11):1508-12. PubMed ID: 2997407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of vinblastine in small cell carcinoma of the lung.
    Sörenson S; Osterlind K; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1983 Mar; 67(3):293-5. PubMed ID: 6299548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy with carboplatin, etoposide, and vincristine as first-line treatment in small-cell lung cancer.
    Gatzemeier U; Hossfeld DK; Neuhauss R; Reck M; Achterrath W; Lenaz L
    J Clin Oncol; 1992 May; 10(5):818-23. PubMed ID: 1314891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
    Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
    Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vincristine, Adriamycin, cyclophosphamide, and etoposide (VP16-213) in small-cell anaplastic carcinoma of the lung.
    von Eyben FE; Arwidi A; Hellekant C; Jonsson K; Lindahl SA; Mattsson W; Tennvall L
    Cancer Chemother Pharmacol; 1982; 7(2-3):195-7. PubMed ID: 6282483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of carboplatin and vincristine in previously treated patients with small-cell lung cancer.
    Smit EF; Berendsen HH; de Vries EG; Mulder NH; Postmus PE
    Cancer Chemother Pharmacol; 1989; 25(3):202-4. PubMed ID: 2557171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study.
    Ettinger DS; Finkelstein DM; Abeloff MD; Skeel RT; Stott PB; Frontiera MS; Bonomi PD
    J Natl Cancer Inst; 1992 Jul; 84(14):1077-84. PubMed ID: 1320131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of CI-980 in previously untreated extensive small cell lung cancer: an Ohio State University phase II research consortium study.
    Thomas JP; Moore T; Kraut EH; Balcerzak SP; Galloway S; Vandre DD;
    Cancer Invest; 2002; 20(2):192-8. PubMed ID: 11901539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide, vincristine and sequential split-course radiotherapy in the treatment of small cell lung cancer.
    Holoye PY; Samuels ML
    Chest; 1975 Jun; 67(6):675-9. PubMed ID: 165045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancer.
    Bishop JF; Kefford R; Raghavan D; Zalcberg J; Stuart-Harris R; Ball D; Olver IN; Friedlander M; Bull C; Yuen K
    Cancer Chemother Pharmacol; 1990; 25(5):367-70. PubMed ID: 2155064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of continuous-infusion cisplatin.
    Posner MR; Skarin AT; Clark J; Ervin TJ
    Cancer Treat Rep; 1986 Jul; 70(7):847-50. PubMed ID: 3013401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).
    Thomas CR; Giroux DJ; Stelzer KJ; Craig JB; Laufman LR; Taylor SA; Goodwin JW; Crowley JJ; Livingston RB
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1039-47. PubMed ID: 9539558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.